Literature DB >> 30965338

Morphological and Immunophenotypic Clues to the WHO Categories of Acute Myeloid Leukaemia.

Barbara J Bain1, Marie C Béné2.   

Abstract

Diagnosis and classification of acute myeloid leukaemia (AML) require cytogenetic and molecular genetic investigation. However, while these evaluations are pending, morphology supplemented by immunophenotyping can provide clues to the diagnosis of specific cytogenetic/genetic categories of AML. Most importantly, acute promyelocytic leukaemia can be diagnosed with a high degree of certainty. However, provisional identification of cases associated with t(8; 21), inv(16), t(1; 22), and NPM1 mutation may also be possible. In addition, transient abnormal myelopoiesis of Down's syndrome can generally be diagnosed morphologically.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Acute myeloid leukaemia; Immunophenotyping; Morphology; World Health Organisation classification

Mesh:

Substances:

Year:  2019        PMID: 30965338     DOI: 10.1159/000496097

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  10 in total

1.  Minimal residual disease and stem cell transplantation outcomes.

Authors:  Jacqueline Cloos; Gert J Ossenkoppele; Richard Dillon
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Morphological, fractal, and textural features for the blood cell classification: the case of acute myeloid leukemia.

Authors:  Marko Dinčić; Tamara B Popović; Milica Kojadinović; Alexander M Trbovich; Andjelija Ž Ilić
Journal:  Eur Biophys J       Date:  2021-10-12       Impact factor: 1.733

3.  Comment: In Response to "CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML"

Authors:  Smeeta Gajendra
Journal:  Turk J Haematol       Date:  2020-11-19       Impact factor: 1.831

Review 4.  Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment.

Authors:  Thomas B Alexander; Etan Orgel
Journal:  Curr Oncol Rep       Date:  2021-02-05       Impact factor: 5.075

5.  Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia.

Authors:  Jean Philippe Vial; Nicolas Lechevalier; Francis Lacombe; Pierre-Yves Dumas; Audrey Bidet; Thibaut Leguay; François Vergez; Arnaud Pigneux; Marie C Béné
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

6.  Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS.

Authors:  Eline J M Bertrums; C Michel Zwaan; Daisuke Hasegawa; Valerie De Haas; Dirk N Reinhardt; Franco Locatelli; Barbara De Moerloose; Michael Dworzak; Arjan Buijs; Petr Smisek; Alexandra Kolenova; Cornelis Jan Pronk; Jan-Henning Klusmann; Ana Carboné; Alina Ferster; Evangelia Antoniou; Soheil Meshinchi; Susana C Raimondi; Charlotte M Niemeyer; Henrik Hasle; Marry M Van den Heuvel-Eibrink; Bianca F Goemans
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

Review 7.  The dual role of autophagy in acute myeloid leukemia.

Authors:  Wonhyoung Seo; Prashanta Silwal; Ik-Chan Song; Eun-Kyeong Jo
Journal:  J Hematol Oncol       Date:  2022-05-07       Impact factor: 23.168

8.  Combined Effects of Tanshinone IIA and an Autophagy Inhibitor on the Apoptosis of Leukemia Cells via p53, Apoptosis-Related Proteins and Oxidative Stress Pathways.

Authors:  Ying-Chyi Song; Cheng-Chieh Kuo; Chuan-Teng Liu; Tsai-Chen Wu; Yi-Ting Kuo; Hung-Rong Yen
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

9.  The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia.

Authors:  Vinh Thanh Tran; Thang Thanh Phan; Hong-Phuoc Mac; Tung Thanh Tran; Toan Trong Ho; Suong Phuoc Pho; Van-Anh Ngoc Nguyen; Truc-My Vo; Hue Thi Nguyen; Thao Thi Le; Tin Huu Vo; Son Truong Nguyen
Journal:  BMC Res Notes       Date:  2020-08-26

10.  Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1+ acute myeloid leukemia by flow cytometry.

Authors:  Monali Gupta; Katayoon Jafari; Amr Rajab; Cuihong Wei; Joanna Mazur; Anne Tierens; Elizabeth Hyjek; Rumina Musani; Anna Porwit
Journal:  Cytometry B Clin Cytom       Date:  2020-12-10       Impact factor: 3.058

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.